百聯股份(600827.SH)控股股東完成增持 累計增持1778.798萬股
格隆匯2月13日丨百聯股份(600827.SH)公佈,公司控股股東百聯集團計劃於2019年11月13日起6個月內,通過上海證券交易所集中競價交易系統以其自有或自持資金增持公司A股普通股,累計增持比例(含本次已增持股份)不低於公司總股本的0.5%,不超過公司總股本的0.997%。
自2019年11月13日至2020年2月13日,百聯集團通過上海證券交易所集中競價交易系統增持公司A股普通股1778.798萬股,佔公司總股本的0.997%,增持金額為1.50億元,增持均價為8.44元/股,本次增持計劃實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.